»  Timeline
1994 Establishment of the CinnaGen Company

1995 Marketing Taq DNA polymerase

1997 Marketing Molecular Diagnostic kits such as HIV, HBV, HCV, H.pylori,... and MTB (PCR based technology)

1999 PCR based research kit such as RT-PCR system

2000 Synthetic peptides for Veterinary use, Luliberin (GnRH analog)

2002 T4 DNA ligase, Restriction Enzymes (EcoRI, BamHI , HindIII , HindII, NotI)

2003 Monoclonal Antibodies for Blood Group typing (Anti-A, Anti-B, and Anti-D)

2005 DNA and RNA extraction kits (RNX™, DNG™ and DNP™)

2006 Launching CinnaGen’s products to more than 18 countries

2007 Launching CinnoVex™ (recombinant Interferon beta 1a) in the market in collaboration with Fraunhofer Institute, Germany, as the second manufacturer in the world after Biogen – Idec.

2007 Launching Buserelin acetate based on synthetic peptide technology for human used.

2007 Begining registration of CinnoVex™ in 5 countries including two European Countries.

2008 Clinical studies of EPO and CinnaRelief (IFN-. 1a)

2008 re-Hu FSH and PTH in the pipeline.